Eva Renee Barnett is CFO at Immunovant, Inc. (IMVT). They have made 24 open-market trades across 1 company since 2022, most recently 2025-04-16.
CIK 0001883766
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 24 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| IMVT | 396,774 | $10.6M |
Shares reported on the most recent Form 4, priced at the 2025-04-17 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| IMVT | SELL | 2025-04-16 | 2025-04-17 | $14.89 | $45K | +10.4% | +0.5% | +21.7% |
| IMVT | SELL | 2025-04-09 | 2025-04-11 | $12.99 | $287K | -0.6% | -4.0% | +15.4% |
| IMVT | SELL | 2025-02-19 | 2025-02-21 | $20.86 | $117K | -8.4% | -8.3% | -31.4% |
| IMVT | SELL | 2025-01-15 | 2025-01-17 | $23.82 | $107K | -8.2% | -13.4% | -37.0% |
| IMVT | SELL | 2025-01-08 | 2025-01-10 | $24.10 | $198K | +2.8% | -14.3% | -35.0% |
| IMVT | SELL | 2024-11-20 | 2024-11-22 | $25.45 | $212K | +4.4% | -5.3% | -24.8% |
| IMVT | SELL | 2024-10-16 | 2024-10-18 | $28.79 | $188K | +2.3% | -13.6% | -19.3% |
| IMVT | SELL | 2024-10-09 | 2024-10-11 | $29.56 | $305K | -1.4% | +2.3% | -22.9% |
| IMVT | SELL | 2024-08-21 | 2024-08-23 | $31.85 | $235K | +3.8% | -12.5% | -18.1% |
| IMVT | SELL | 2024-07-17 | 2024-07-19 | $29.67 | $180K | +3.1% | +10.6% | +3.8% |
| IMVT | SELL | 2024-07-09 | 2024-07-10 | $28.06 | $266K | -9.4% | -5.4% | -4.1% |
| IMVT | SELL | 2024-05-22 | 2024-05-24 | $29.65 | $240K | -12.7% | -6.1% | +7.8% |
| IMVT | SELL | 2024-04-17 | 2024-04-19 | $29.06 | $712K | -0.2% | +8.0% | -0.6% |
| IMVT | SELL | 2024-04-09 | 2024-04-10 | $31.18 | $230K | -6.4% | -4.3% | -3.3% |
| IMVT | SELL | 2024-02-22 | 2024-02-23 | $36.15 | $212K | -9.8% | -14.8% | -22.5% |
| IMVT | SELL | 2024-01-11 | 2024-01-12 | $41.75 | $259K | -9.1% | -12.8% | -27.0% |
| IMVT | SELL | 2023-11-22 | 2023-11-24 | $32.76 | $261K | +16.8% | +32.2% | +7.7% |
| IMVT | SELL | 2023-10-10 | 2023-10-11 | $36.92 | $336K | -8.0% | -11.2% | +19.2% |
| IMVT | SELL | 2023-08-24 | 2023-08-25 | $20.30 | $584K | +14.7% | +1.1% | +66.6% |
| IMVT | SELL | 2023-07-19 | 2023-07-20 | $24.94 | $136K | +0.0% | -10.8% | +60.2% |
| IMVT | SELL | 2023-04-18 | 2023-04-19 | $15.27 | $105K | +13.1% | +36.1% | +60.1% |
| IMVT | SELL | 2023-01-11 | 2023-01-13 | $16.75 | $151K | -3.5% | -0.8% | -15.8% |
| IMVT | SELL | 2022-10-11 | 2022-10-13 | $9.44 | $118K | +9.9% | +35.0% | +88.7% |
| IMVT | SELL | 2022-01-07 | 2022-01-11 | $7.25 | $434K | -13.3% | -30.3% | -38.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.